Related Experiment Video
Updated: Jun 6, 2026

05:21
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
Published on: September 12, 2025
Laparoscopic conversion rate for uterine cancer surgical staging
James Fanning1, Carrie Hossler
1From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
Obstetrics and Gynecology
|November 25, 2010
Summary
Laparoscopic staging for endometrial adenocarcinoma is feasible with a low overall conversion rate. However, patients with a high body mass index (BMI) face increased risks of conversion during the procedure.
Area of Science:
- Gynecologic Oncology
- Minimally Invasive Surgery
Background:
- Endometrial adenocarcinoma is a common gynecologic malignancy.
- Laparoscopic staging is a standard surgical approach.
- Obesity presents challenges in gynecologic surgery.
Purpose of the Study:
- To determine the conversion rate of attempted laparoscopic staging for primary endometrial adenocarcinoma.
- To identify factors associated with conversion to open surgery.
Main Methods:
- A consecutive series of 235 patients with primary endometrial adenocarcinoma underwent attempted laparoscopic staging.
- No exclusion criteria were applied, including age, BMI, uterine size, or prior surgery.
- Data on operative outcomes and conversion rates were collected.
Main Results:
- The overall conversion rate to laparotomy or vaginal hysterectomy was 3% (6 out of 235 patients).
- All conversions occurred in patients with a body mass index (BMI) greater than 40 kg/m².
- Patients converted had a mean BMI of 66 kg/m².
Conclusions:
- Laparoscopic staging for endometrial adenocarcinoma is achievable with a low overall conversion rate.
- Patients with a BMI of 40 kg/m² or higher had a higher conversion rate (7%) compared to the overall cohort.
- Obesity is a significant factor influencing the success of laparoscopic staging in endometrial cancer.
